Tag Archives: Mexico

Mexico’s Healthcare Market Value “to Reach Almost $28 Billion by 2020″

Mexico’s pharmaceutical industry will be worth approximately US$22.5 billion by 2020, according to research and consulting firm GlobalData. Combined with the medical devices industry — expected to be worth US$5.4 billion by the same time — the total value of Mexico’s healthcare market value will be $27.9 billion. GlobalData reports that this overall increase in Mexico’s […]
Posted in Emerging Markets, Global | Also tagged , , | Leave a comment

Future Brighter for MNCs in Mexico, Says Report

Despite Mexico’s efforts to improve its regulatory framework and create a better business environment for pharma, the market share of generic drugs still makes it difficult for multinationals to materialize their commercial benefit. However, a new report from Business Monitor forecasts that, in the long term, Mexico’s improving private health insurance sector and potentially significant investment from […]
Posted in Emerging Markets, Global, healthcare | Also tagged , | Leave a comment

Going Global: The New Pharma Workforce

Mexico and other emerging markets top the skills gap list By Susan Crowley Finding the right people for the right job might seem an afterthought for big Pharma companies that have cut their US workforce by more than 250,000 in the past 10 years.  But the rush is back on for talent:  the challenge is […]
Posted in Emerging Markets, Global, Guest Blog | Also tagged , , | 1 Comment

Battling Chronic Disease in Mexico

The objectives of the Workplace Wellness & Prevention Council of Mexico could lead to a win-win situation that may serve as a model for other developing countries around the world. In 2003, Abner Mason started a non-profit in Mexico. The AIDS Responsibility Project’s primary function was to campaign against discrimination of people with AIDS and […]
Posted in Emerging Markets, Global, healthcare | Also tagged , | 4 Comments

GSK Signs $120M Deal to Market DMab Overseas

Image via Wikipedia In an effort to boost its sales force without hiring more sales reps, Amgen announced on Tuesday that it has signed a deal with GlaxoSmithKline to co-market its osteoporosis treatment denosumab—currently pending FDA approval. GSK will paying $120 million up front (along with royalties) to mutually market denosumab, or DMab, in regions […]
Posted in Deals, News, Technology | Also tagged , , , , , , , , , , | 1 Comment
  • Categories

  • Meta